Health Trials

FIGO Stage III and IV Ovarian Cancer

2

Review clinical trials related to FIGO Stage III and IV Ovarian Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer

A Phase 1B/2 Study to Investigate the Safety and Efficacy of TORL-1-23 with Chemotherapy Given Before Initial Surgery in Women with Advanced Stage Ovarian Cancer

Participants needed: 60
Trial details
Phase: Phase 1, Phase 2Age: 18-75Biological sex: FemaleType: InterventionalSponsor: TORL Biotherapeutics, LLCUpdated: Jul 13, 2026Locations: 7
Eligibility criteria

Eastern Cooperative Oncology Group (ECOG) performance status 0 to 1 [+4]

Clear cell, mucinous, sarcomatous, mixed histology, low-grade/borderline, or non... [+8]

Read more
Status: Recruiting

CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer

A Phase 1B/2 Study to Investigate the Safety and Efficacy of TORL-1-23 with Chemotherapy Given Before Initial Surgery in Women with Advanced Stage Ovarian Cancer

Participants needed: 60
Trial details
Phase: Phase 1, Phase 2Age: 18-70Biological sex: FemaleType: InterventionalSponsor: TORL Biotherapeutics, LLCUpdated: Jan 7, 2026Locations: 1
Eligibility criteria

Eastern Cooperative Oncology Group (ECOG) performance status less than or equal... [+4]

Clear cell, mucinous, sarcomatous, mixed histology, low-grade/borderline, or non... [+7]

Read more